{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:37:15Z","timestamp":1793367435362,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.radcr.2026.06.121","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:11:34Z","timestamp":1784635894000},"page":"4686-4692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti leucine-rich glioma-inactivated 1 (LGI1) antibody-positive limbic encephalitis with evolving basal ganglia T1WI hyperintensity: A case report"],"prefix":"10.1016","volume":"21","author":[{"given":"Ryoko","family":"Noha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-8286","authenticated-orcid":false,"given":"Akira","family":"Yogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2121-2232","authenticated-orcid":false,"given":"Yukihiro","family":"Namihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Tomori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanae","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyo","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7103-7757","authenticated-orcid":false,"given":"Akihiro","family":"Nishie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.radcr.2026.06.121_bib0001","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00234-024-03318-x","article-title":"Autoimmune encephalitis: what the radiologist needs to know","volume":"66","author":"Sanvito","year":"2024","journal-title":"Neuroradiology"},{"issue":"1093","key":"10.1016\/j.radcr.2026.06.121_bib0002","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170869","article-title":"Autoimmune epilepsy: findings on MRI and FDG-PET","volume":"92","author":"Guerin","year":"2018","journal-title":"Br J Radiol"},{"issue":"6","key":"10.1016\/j.radcr.2026.06.121_bib0003","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000161","article-title":"Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures","volume":"2","author":"Flanagan","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.radcr.2026.06.121_bib0004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.radcr.2026.06.121_bib0005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s13760-020-01336-z","article-title":"Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis","volume":"121","author":"Li","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.radcr.2026.06.121_bib0006","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/NDT.S292343","article-title":"Clinical features and long-term outcomes of anti-leucine-rich glioma-inactivated 1 encephalitis: a multi-center study","volume":"17","author":"Qiao","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"10.1016\/j.radcr.2026.06.121_bib0007","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"issue":"19","key":"10.1016\/j.radcr.2026.06.121_bib0008","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1212\/WNL.0000000000007475","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis","volume":"92","author":"de Bruijn","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.radcr.2026.06.121_bib0009","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"issue":"28","key":"10.1016\/j.radcr.2026.06.121_bib0010","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004244","article-title":"Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures","volume":"95","author":"Li","year":"2016","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.radcr.2026.06.121_bib0011","article-title":"Predictors and clinical characteristics of relapses in LGI1-antibody encephalitis","volume":"11","author":"Campetella","year":"2024","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.radcr.2026.06.121_bib0012","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.radcr.2026.06.121_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.618109","article-title":"Brain magnetic resonance imaging characteristics of anti-leucine-rich glioma-inactivated 1 encephalitis and their clinical relevance: a single-center study in China","volume":"11","author":"Shao","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.radcr.2026.06.121_bib0014","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5692\/clinicalneurol.cn-002084","article-title":"Anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis diagnosed from T1 signal intensity changes in basal ganglia: a case report and literature review","volume":"65","author":"Kita","year":"2025","journal-title":"Rinsho Shinkeigaku"},{"issue":"11","key":"10.1016\/j.radcr.2026.06.121_bib0015","doi-asserted-by":"crossref","DOI":"10.5692\/clinicalneurol.cn-001460","article-title":"Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis","volume":"60","author":"Ishibashi","year":"2020","journal-title":"Rinsho Shinkeigaku"},{"issue":"4","key":"10.1016\/j.radcr.2026.06.121_bib0016","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000248","article-title":"LGI1 antibody encephalopathy overlapping with sporadic Creutzfeldt-Jakob disease","volume":"3","author":"Kim","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.radcr.2026.06.121_bib0017","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4103\/0028-3886.338681","article-title":"Bi-Basal ganglia involvement with signal evolution in a case of anti-LGI1 encephalitis","volume":"70","author":"Gai","year":"2022","journal-title":"Neurol India"},{"key":"10.1016\/j.radcr.2026.06.121_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.620483","article-title":"Case report: anti-LGI1 limbic encephalitis associated with anti-thyroid autoantibodies","volume":"11","author":"Otiniano-Sifuentes","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.radcr.2026.06.121_bib0019","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200158","article-title":"LGI1 encephalitis and IgG4-related disease","volume":"10","author":"Jesuthasan","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.radcr.2026.06.121_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/epd2.20300","article-title":"Status epilepticus with bilateral basal ganglia hyperintensity in anti-LGI1 encephalitis","volume":"27","author":"Wang","year":"2025","journal-title":"Epileptic Disord"},{"issue":"1","key":"10.1016\/j.radcr.2026.06.121_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001429","article-title":"Autoimmune encephalitis associated with anti-LGI1 antibody: a potential cause of neuropsychiatric systemic lupus erythematosus","volume":"12","author":"Chen","year":"2025","journal-title":"Lupus Sci Med"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043326005662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043326005662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:56:49Z","timestamp":1793365009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043326005662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1930043326005662"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2026.06.121","relation":{},"ISSN":["1930-0433"],"issn-type":[{"value":"1930-0433","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti leucine-rich glioma-inactivated 1 (LGI1) antibody-positive limbic encephalitis with evolving basal ganglia T1WI hyperintensity: A case report","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2026.06.121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}